AVTAVT-treatedChronic hepatitis B (CHB)MASLDinflammatory liver diseasemetabolic dysfunction-associated steatotic liver disease (MASLD)
…ted HepG2-NTCP cells and this effect was not fully abrogated by AVT.Conclusions CHB is characterised by persistent expansion of met…